Leading medical organizations team up to bring new TB treatments to those in need

03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).

By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.

Read the article on MSF website


Related Articles

Mandate for ICRC’s President extended for third term

11/29/2019. Peter Maurer will serve a third mandate as president of the International Committee of the Red Cross following a vote by the ICRC’s governing body, the Assembly, on 28 November 2019.

Russia scores victory for ally Syria in UN vote cutting aid

01/11/2020. Russia scored a victory for its close ally Syria, using its veto threat to force the U.N. Security Council to adopt a resolution significantly reducing the delivery of cross-border humanitarian aid to over one million Syrians in the northeast.

Someday Disposable Drones May Deliver A Payload, Then Vanish

03/02/2017. DARPA is working with several companies in the field of ephemeral materials to achieve a prototype.